deltatrials
Completed PHASE3 NCT00119704

Treatment of Tennis Elbow With Botulinum Toxin

Treatment of Lateral Epicondylitis With Botulinum Toxin: A Randomized Controlled Trial

Sponsor: Chinese University of Hong Kong

Conditions Epicondylitis, Lateral Humeral
Interventions Botulinum toxin A injection or normal saline
Updated 5 times since 2017 Last updated: May 8, 2006 Started: Sep 30, 2002 Completion: Mar 31, 2005

A PHASE3 clinical study on Epicondylitis, Lateral Humeral, this trial is completed. The trial is conducted by Chinese University of Hong Kong and has accumulated 5 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Sep 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Chinese University of Hong Kong
  • New World Development Company Limited
Data source: Chinese University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Shatin, New Territories, Hong Kong
  • • Sheung Shui, New Territories, Hong Kong